Menu Close

Kara Vine-Perrow

Research Fellow and Group Leader of the Targeted Therapeutics Research Laboratory, University of Wollongong

Dr Vine-Perrow's independent research program is focused on (i) understanding the mechanisms that drive chemotherapeutic drug resistance in cancer and (ii) the development and characterization of novel nanomedicines and medical devices for site‐specific drug delivery.

Her group designs customisable drug delivery platforms that enhance drug solubility, enable targeted delivery, and provide improved therapeutic efficacy with reduced toxicity profiles. Specifically she focuses on the development of (i) drug encapsulated polymeric micelles to overcome multidrug resistance in cancer; (ii) dual‐drug eluting polymeric implants for the treatment of locally advanced pancreatic cancer; and (iii) targeted liposomes for the treatment of metastatic breast cancer.

More recently the Vine-Perrow group has applied their drug delivery knowledge to neurodegenerative diseases, specifically Motor Neurone Disease, to improve the delivery of antisense oligonucleotides to the CNS using calcium phosphate lipid nanoparticles.

Experience

  • –present
    Research Fellow and Group Leader of the Targeted Therapeutics Research Laboratory, University of Wollongong

Education

  • 2007 
    University of Wollongong , PhD/ Molecular Biology